Cappelli, L. C., Kwong, B., Naidoo, J., Leventhal, J., Lacouture, M. E., Mooradian, M. J., . . . Shariff, A. Defining D-irAEs: Consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCappelli, Laura C., et al. Defining D-irAEs: Consensus-based Disease Definitions for the Diagnosis of Dermatologic Adverse Events from Immune Checkpoint Inhibitor Therapy. BMJ Publishing Group.
MLA (9th ed.) CitationCappelli, Laura C., et al. Defining D-irAEs: Consensus-based Disease Definitions for the Diagnosis of Dermatologic Adverse Events from Immune Checkpoint Inhibitor Therapy. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.